Product Images Carvedilol

Each tablet contains 12.5mg of Carvedilol and has the NDC 72888-036-00. It is important to keep it below 30°C (86°F) and protected from moisture. The carvedilol tablets should not be accepted if the seal under the cap is broken or missing. They should be dispensed in a tightly closed, light-resistant container. The dosage instructions can be found in the accompanying prescribing information. The manufacturing licensee is Rubicon Research Private Limited, located in Ambernath, Dist. Thane, 421506, India. The product is distributed by Advagen Pharma Limited from their office located at 666 Plainsboro Road Suite 605, Plainsboro, NJ, 08536, USA.*

Each tablet of Carvedilol 12.5 mg is intended to be dispensed in a tight, light-resistant container. It is manufactured by Rubicon Research Private Limited and distributed by Advagen Pharma Limited from Plainsboro, New Jersey, USA. The tablet should be stored below 30°C (86°F) and protected from moisture. The prescription should be accompanied by prescribing information, and the dosage should be followed. The seal under the cap should not be accepted if broken or missing. The overprinted area, Tablets USP Mg L No K082 2, indicates the strength and identity of the tablets.*

Each tablet of this medication contains 125mg of carvedilol, which is dispensed in a tightly sealed, light-resistant container. The medication is distributed by Advagen Pharma Limited located in Plainsboro, New Jersey. The medication is manufactured by Rubicon Research Private Limited located in Ambernath, India. The medication should be stored below 30°C (86°F) and protected from moisture. The prescribing information should be consulted for dosage instructions. A prescription is required to obtain this medication.*

This is a description for a medication called Carvedilol, with a strength of 25mg, contained within tablets, each table labeled with code NpC 72888-037-01. It is recommended to store the medication below 30°C (86°F) and protected from moisture. Users should check if the seal under the cap of the tablet is broken before accepting. The medication should be dispensed in a tight, light-resistant container in quantities of 100 tablets and can only be obtained with a doctor's prescription. Dosage information is included with the prescription information. The medication is distributed in the USA, and the manufacturing company is Rubicon Research Private Limited, located in Ambernath, India, with manufacturing license number KD-682 21147, and an overprinting area measuring 45 mm X 20 mm.*

Each tablet contains 25 mg of carvedilol and should be stored in a tightly sealed container below 30°C to protect it from moisture. The tablets come with accompanying prescribing information and should not be accepted if the seal under the cap is missing or broken. This product is distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited in India.*

Each tablet of Carvedilol contains 25mg of the medicine. It is important to store it below 30°C (86°F) and protect it from moisture. The tablets should not be accepted if the seal under the cap is missing or broken. It should be dispensed in a tightly closed light-resistant container. Carvedilol comes in a pack of 500 tablets and is available only through a prescription. Dosage instructions can be found in the prescribing information. The medicine is distributed by Advagen Pharma Limited, located in Plainsboro, NJ, and manufactured by Rubicon Research Private Limited in India. The manufacturing license number is KD-682 21148. There is an overprinting area of 55 mm X 20 mm.*

This is a description of medication containing carvedilol available in tablet form. Each tablet contains 3.125mg of carvedilol and is stored below 30°C. The tablets are USP certified and should be protected from moisture. The bottle of tablets should not be accepted if the seal under the cap is missing or broken. Dispense in a tightly sealed, light-resistant container, and the bottle contains 1000 tablets that are only available through prescription. Dosage information is provided in the accompanying prescribing information. The product is distributed by Advagen Pharma Limited located in Plainsboro, NJ, USA. The product is manufactured by Rubicon Research Private Limited located in India.*

This is a description of a medication called Carvedilol, which comes in tablet form. Each tablet contains 3.125mg of the active ingredient. The medication should be stored below 30°C and protected from moisture, and should be dispensed in a tight, light-resistant container. The prescribing information should be consulted for dosage instructions, and the medication should not be accepted if the seal under the cap is broken or missing. The medication is distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited.*

This is a prescription medicine containing 3.125mg of carvedilol per tablet, produced by Rubicon Research Private Limited and distributed by Advagen Pharma Limited. The medicine should be stored in a cool and dry place, away from moisture, below 30°C (86°F). The prescription information details the dosage recommendations and warns not to use the medicine if the seal under the cap is missing or broken. The tablets come in a tightly sealed container. The NDC (National Drug Code) number is 72888-034-30 and the license number is KD-682 21134.*

Each tablet of carvedilol contains 3.125mg and should be dispensed in a tight, light-resistant container. It is distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited. The tablets should be stored below 30°C (86°F) and protected from moisture. The prescribing information should be consulted for dosage instructions. The tablets are only available on prescription and should not be accepted if the seal under the cap is missing or broken.*

This is a description of Carvedilol tablets manufactured by Rubicon Research in India and distributed by Advagen Pharma in the USA. Each tablet has 6.25 mg of Carvedilol and is packaged in a container with instructions to protect it from moisture and store below 30°C. The prescription drug should not be used if the seal under the cap is missing or broken and comes with additional prescribing information. The overprinting area is 50 mm X 15 mm.*

Each tablet of Carvedilol contains 6.25 mg of the medication and is packaged in a tightly sealed, light-resistant container to protect it from moisture. It is distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited. The prescribed dosage can be found in the accompanying prescribing information. The tablets should be stored at a temperature below 30°C and not used if the seal under the cap is missing or broken. This medication is available only by prescription.*

Each tablet contains 6.25mg of carvedilol and should be dispensed in a tight, light-resistant container. It is distributed by Advagen Pharma Limited, located in Plainsboro, NJ, and manufactured by Rubicon Research Private Limited. The tablets' prescribing information should be consulted for dosage recommendations. It is important to store the tablets below 30°C (86°F) and protect them from moisture. Do not accept the tablets if the seal under the cap is missing or broken. Additional details are not-available due to lack of data.*

Each tablet contains 6.25mg of Carvedilol, a medication used to treat high blood pressure and heart failure. The tablets should be stored at temperatures below 30°C and protected from moisture. Patients are advised not to use the tablets if the seal is missing or broken, and they should be dispensed in a tightly sealed, light-resistant container. Dosage information is provided on the prescribing information that accompanies the medication. The packaging consists of 500 tablets and bears the brand name Advagen with an NDC code of 72888-035-05. This medication is for prescription use only and is manufactured by Rubicon Research in India and distributed by Advagen Pharma in Plainsboro, NJ, USA.*

This appears to be a table with various medical parameters such as gender, age, medical conditions like diabetes, ischemia, heart rate, and medication names. There are also some symbols on the table. Without more context or a clear description of what the table is intended to show, it cannot be further evaluated.*